Clinical Trial Update: A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

View source ↗

Summary

A retrospective review of gemcitabine, methylprednisolone, cisplatin (GEM-P) with or without rituximab in relapsed/refractory diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Gemzar (gemcitabine)
• MEDROL (METHYLPREDNISOLONE)
• Platinol (cisplatin)
• Rituxan (rituximab)

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Non-Hodgkins Lymphoma | Status: COMPLETED